The effects of saponins on the inhibition or suppression of AD pathogenesis were determined by quantifying the levels of inflammatory cytokines (IL-1B, IL-6, and TNF alpha) in glial cells using specific ELISA kits. This evidence concerns the gene TNF and Alzheimer disease.